Upcoming Symposium on Autoantibodies – Preliminary Programm

From September 9 to 12, 2025, the 17th Dresden Symposium on Autoantibodies will take place in Dresden, Germany. This year’s theme, “The Autoantibody Spectrum: Bridging Health, Diagnostics, and Disease,” brings together global experts for a deep dive into the evolving science of autoimmune diagnostics. The event also honors the legacy of Prof. Eng M. Tan, a pioneer in the field.

Medipan & GA Generic Assays are proud to sponsor a Satellite Symposium on Thursday, September 11, focused on ANA testing, AI-driven antibody detection, and emerging autoantigenic targets.

A day before the official start, a pre-symposium will host the 8th ICAP (International Consensus on ANA Patterns) Workshop with a focus on advances in HEp-2 IFA pattern classification, artificial intelligence in ANA interpretation, and quality control challenges.

📌 Main Symposium Sessions

Day 1: Tuesday, September 9

• Opening Lectures: Insightful talks on the history of autoantibody detection, autoimmune pathogenesis, and the life work of Prof. Tan.
• Rheumatoid Arthritis: A deep dive into updated autoantibody profiling, including IgA anti-citrullinated protein antibodies and anti-type II collagen antibodies.
• Innovations in Early Diagnosis: Focus on novel biomarkers and strategies to improve early identification of autoimmune diseases.
•  

 Day 2: Wednesday, September 10

• Neurological Autoimmunity: Emerging serological insights into myasthenia gravis, autoimmune dementia, and encephalitis.
• Antiphospholipid Syndrome (APS): Analysis of 2023 ACR/EULAR criteria, likelihood ratios, and non-criteria aPL antibodies.
• Interstitial Lung Disease (ILD) in Autoimmunity: New markers and methods, including immunoprecipitation–mass spectrometry.
• IgG4-mediated Diseases: Diagnostic and clinical relevance of IgG4 antibodies in systemic and neurological conditions.

Day 3: Thursday, September 11

• Emerging Technologies: ANA and AI-driven autoantibody detection, and novel autoantigenic targets like glycoprotein 2.
• Immune Checkpoint Inhibitors: Immunogenicity and immune-related adverse events affecting dermatologic and neurologic systems.
• Autoantibody Monitoring: Updates on immunomarkers for long-term management of autoimmune diseases such as lupus and celiac disease.
• Natural vs. Pathogenic Autoantibodies: Exploring regulatory roles and protective aspects of specific antibodies.

Day 4: Friday, September 12

• Testing Culture in Autoimmunity: A debate on overtesting vs. undertesting while rising autoimmune prevalence.
• Innovative Therapies: Novel treatments including AlloNK cell infusions and CAR T-cell therapy for refractory autoimmune diseases.
• Biomarker Discovery: The future of autoimmune diagnostics through orphan antibodies, autoantigenomics, and disease-specific markers.

🧭 Why Attend?

The 17th Dresden Symposium on Autoantibodies offers direct access to the latest advances in autoimmune diagnostics—spanning AI-powered testing, early-stage biomarkers, emerging therapies, and updated clinical criteria. The Dresden Symposium is a must-attend for researchers, clinicians, and laboratory professionals, and everyone working in the field of autoimmune diagnostics.